Harbor:Non-Occupational Exposure: Difference between revisions
(Link to Harbor:Sexual assault page with detailed Harbor-specific procedures) |
|||
| Line 17: | Line 17: | ||
** OLD Resource https://emedharbor.labiomed.org/private/Contact%20Info/ED%20Documents/Sexual%20Assault%20Protocol.pdf | ** OLD Resource https://emedharbor.labiomed.org/private/Contact%20Info/ED%20Documents/Sexual%20Assault%20Protocol.pdf | ||
*** | ***High risk exposure (partner or assailant in the case of sexual assault has unknown HIV status, is known HIV+ or highly likely to be HIV+ with a high viral load and the sexual activity was associated with a high risk of transmission, e.g., receptive anal intercourse, sexual assault with vaginal trauma), occurring within the prior 72 hours. Sexual assault victims should be offered Tenofovir/Emtricitabine (Truvada) 200/300 mg daily plus Raltegravir 400 mg BID and should be referred immediately to a SART center for STI prophylaxis and Plan B contraception. If the patient meets these criteria, then first dose of non-occupational PEP gave be given in ED. We are working on a process to give patient's few doses to go home with to tie them over until they can get the 28d course needed from a PEP center. | ||
***For the vast majority of cases in which a patient seeks post-sexual-exposure/non-occupational HIV prophylaxis (nPEP), the patient should also be referred to a PEP center to obtain the additional medications and follow up labs, such as the Los Angeles LGBT Center. The LA LGBT Gay and Lesbian Center has a program for post-exposure prophylaxis in a number of specific circumstances; patients can be referred within 72 hours of an exposure. Their hours are Mon-Friday 11am-6pm (telephone number is 323-860-5855, and their website is https://lalgbtcenter.org/post-exposure-prophylaxis). | |||
***For the vast majority of cases in which a patient seeks post-sexual-exposure HIV prophylaxis, the patient should | ***If you happen to see a patient who meets the criteria above, then a baseline rapid HIV should be sent to make sure the patient is not already infected, in additional renal function needs to be sent. Tenofovir DF is contraindicated in patients with renal dysfunction (creatinine clearance ≤59 mL/min). For these cases, please consult the HIV or infectious disease team at your site, or the National Clinical Consultations Center’s PEPline at (888) 448-4911 | ||
***If you happen to see a patient who meets the criteria above, then a baseline rapid HIV should be sent to make sure the patient is not already infected. | |||
==See Also== | ==See Also== | ||
Revision as of 21:07, 2 March 2020
General Guidelines
- Stats on Risk: https://www.wikem.org/wiki/HIV_post-exposure_prophylaxis
- CDC Information: http://stacks.cdc.gov/view/cdc/38856.
Harbor ED Policy
- Harbor Sexual Assault algorithm and resources: Harbor:Sexual assault
- Harbor - Detailed "How to" for SART Team: https://www.wikem.org/wiki/File:SART_ED_Protocol_Recommendations.pdf
- Preserve all evidence (skin, urine, clothing) and protect chain of custody; address any life-threatening emergencies as appropriate!
- Limit detailed documentation of described events to avoid future discrepancies
- Closest SART Center is in San Pedro
- Forensic Nurse Specialist (SART Staff) available 24/7 at (562) 497-0147
- LA County Public Health HIV PEP Recommendations: https://www.wikem.org/wiki/File:SART_-_Public_Health_HIV_PEP.pdf
- High-risk HIV exposure: sharing needles with a known HIV-positive partner or a partner of unknown status or unprotected (or failed condom) vaginal intercourse or anal sex
- Los Angeles SART Centers: https://www.wikem.org/wiki/File:SART_Centers.pdf
- Harbor - Detailed "How to" for SART Team: https://www.wikem.org/wiki/File:SART_ED_Protocol_Recommendations.pdf
- OLD Resource https://emedharbor.labiomed.org/private/Contact%20Info/ED%20Documents/Sexual%20Assault%20Protocol.pdf
- High risk exposure (partner or assailant in the case of sexual assault has unknown HIV status, is known HIV+ or highly likely to be HIV+ with a high viral load and the sexual activity was associated with a high risk of transmission, e.g., receptive anal intercourse, sexual assault with vaginal trauma), occurring within the prior 72 hours. Sexual assault victims should be offered Tenofovir/Emtricitabine (Truvada) 200/300 mg daily plus Raltegravir 400 mg BID and should be referred immediately to a SART center for STI prophylaxis and Plan B contraception. If the patient meets these criteria, then first dose of non-occupational PEP gave be given in ED. We are working on a process to give patient's few doses to go home with to tie them over until they can get the 28d course needed from a PEP center.
- For the vast majority of cases in which a patient seeks post-sexual-exposure/non-occupational HIV prophylaxis (nPEP), the patient should also be referred to a PEP center to obtain the additional medications and follow up labs, such as the Los Angeles LGBT Center. The LA LGBT Gay and Lesbian Center has a program for post-exposure prophylaxis in a number of specific circumstances; patients can be referred within 72 hours of an exposure. Their hours are Mon-Friday 11am-6pm (telephone number is 323-860-5855, and their website is https://lalgbtcenter.org/post-exposure-prophylaxis).
- If you happen to see a patient who meets the criteria above, then a baseline rapid HIV should be sent to make sure the patient is not already infected, in additional renal function needs to be sent. Tenofovir DF is contraindicated in patients with renal dysfunction (creatinine clearance ≤59 mL/min). For these cases, please consult the HIV or infectious disease team at your site, or the National Clinical Consultations Center’s PEPline at (888) 448-4911
- OLD Resource https://emedharbor.labiomed.org/private/Contact%20Info/ED%20Documents/Sexual%20Assault%20Protocol.pdf
